Designed to Heal
by Jennie A. McLaurin & Cymbeline Tancongco Culiat
What the body shows us about healing wounds, repairing relationships, and restoring community.
Co-authored by NellOne
founder Cymbeline Culiat
490 BioTech and NellOne Expanding Partnership to Fight ARDS
[Knoxville, TN], August 9, 2021 – 490 BioTech and NellOne Therapeutics, Inc., two leaders in Tennessee’s thriving entrepreneurial community and members of its growing biotechnology cluster, announced today they are expanding their partnership to fight against acute...
NellOne CSO Co-Authors Book on the Bodies’ Innate Tissue Healing Responses
A new model and resource for healing social injuries and divisions. [Knoxville, TN], July 26, 2021 – Dr. Cymbeline T. (Bem) Culiat, Co-Founder and Chief Science Officer for NellOne Therapeutics, Inc. (NellOne), along with pediatrician, and public health expert, Dr....
NellOne Awarded Competitive Grant from the National Science Foundation
Small Business Innovation Research Program Provides Seed Funding for R&D [Knoxville, TN], April 26, 2021 – NellOne Therapeutics, Inc. (NellOne) has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I grant for...
NellOne Therapeutics utilizes ORNL’s “COVID-19 Rapid Access Licensing Program”
The novel coronavirus is no doubt top of mind for most people with the infection numbers rising rapidly on a daily, so an announcement last week from Oak Ridge National Laboratory (ORNL) that involves a local early stage biopharmaceutical...
